Christopher Blunden

726 total citations
7 papers, 240 citations indexed

About

Christopher Blunden is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology. According to data from OpenAlex, Christopher Blunden has authored 7 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Medicine, 3 papers in Applied Microbiology and Biotechnology and 2 papers in Pharmacology. Recurrent topics in Christopher Blunden's work include Antibiotic Resistance in Bacteria (3 papers), Antibiotic Use and Resistance (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Christopher Blunden is often cited by papers focused on Antibiotic Resistance in Bacteria (3 papers), Antibiotic Use and Resistance (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Christopher Blunden collaborates with scholars based in United States, Israel and Nigeria. Christopher Blunden's co-authors include Dror Marchaim, Paul Lephart, Suchitha Bheemreddy, Jason M. Pogue, Keith S. Kaye, Kayoko Hayakawa, Teena Chopra, Maryann Shango, Sorabh Dhar and Robert A. Bonomo and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, The Journal of Pediatrics and Infection Control and Hospital Epidemiology.

In The Last Decade

Christopher Blunden

6 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Blunden United States 5 172 93 74 64 60 7 240
Evangelos Vryonis Greece 7 190 1.1× 67 0.7× 100 1.4× 80 1.3× 51 0.8× 11 300
R. Andini Italy 4 187 1.1× 67 0.7× 84 1.1× 56 0.9× 41 0.7× 5 238
Sergio Reyes United States 8 177 1.0× 102 1.1× 82 1.1× 37 0.6× 32 0.5× 13 224
Manuela Aguilar Spain 5 181 1.1× 107 1.2× 77 1.0× 69 1.1× 58 1.0× 5 266
Mónica Gozalo Spain 4 184 1.1× 80 0.9× 54 0.7× 112 1.8× 50 0.8× 6 280
Sarah Won United States 5 192 1.1× 82 0.9× 37 0.5× 67 1.0× 80 1.3× 10 242
Marianna Rossi Italy 4 142 0.8× 93 1.0× 46 0.6× 76 1.2× 51 0.8× 6 210
Islam M. Ghazi United States 10 197 1.1× 101 1.1× 129 1.7× 96 1.5× 28 0.5× 35 320
Julia Guzmán-Puche Spain 9 277 1.6× 130 1.4× 138 1.9× 107 1.7× 61 1.0× 23 321
Ángela Cano Spain 10 278 1.6× 141 1.5× 138 1.9× 118 1.8× 60 1.0× 24 326

Countries citing papers authored by Christopher Blunden

Since Specialization
Citations

This map shows the geographic impact of Christopher Blunden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Blunden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Blunden more than expected).

Fields of papers citing papers by Christopher Blunden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Blunden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Blunden. The network helps show where Christopher Blunden may publish in the future.

Co-authorship network of co-authors of Christopher Blunden

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Blunden. A scholar is included among the top collaborators of Christopher Blunden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Blunden. Christopher Blunden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Rose, Susan R., et al.. (2021). Utility of Repeat Testing for Congenital Hypothyroidism in Infants with Very Low Birth Weight. The Journal of Pediatrics. 242. 152–158.e1. 10 indexed citations
2.
Blunden, Christopher, Elaine M. Urbina, Sarah Lawson, et al.. (2020). Progression of Vasculopathy in Young Individuals with Turner Syndrome. Pediatric Cardiology. 42(3). 481–491. 2 indexed citations
3.
Blunden, Christopher, et al.. (2018). Growth Hormone Therapy for Turner Syndrome.. PubMed. 16(Suppl 1). 80–90. 9 indexed citations
4.
Blunden, Christopher, et al.. (2015). Creating a Standardized Order Set for DKA Admissions to the PICU. American Journal of Medical Quality. 31(1). 93–93.
5.
Marchaim, Dror, Federico Pérez, Jiha Lee, et al.. (2012). “Swimming in resistance”: Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa. American Journal of Infection Control. 40(9). 830–835. 64 indexed citations
6.
Marchaim, Dror, Teena Chopra, Ashish Bhargava, et al.. (2012). Recent Exposure to Antimicrobials and Carbapenem-Resistant Enterobacteriaceae: The Role of Antimicrobial Stewardship. Infection Control and Hospital Epidemiology. 33(8). 817–830. 108 indexed citations
7.
Collins, Vicki L., Dror Marchaim, Jason M. Pogue, et al.. (2012). Efficacy of Ertapenem for Treatment of Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy. 56(4). 2173–2177. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026